Bactiguard Holding AB (CHIX:BACTBs) Effective Interest Rate on Debt % Explanation
Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.
Bactiguard Holding AB Effective Interest Rate on Debt % Related Terms
Bactiguard Holding AB Effective Interest Rate on Debt % Historical Data
* Premium members only.
The historical data trend for Bactiguard Holding AB's Effective Interest Rate on Debt % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bactiguard Holding AB Effective Interest Rate on Debt % Chart
CHIX:BACTBS vs ABT, SYK, MDT: Effective Interest Rate on Debt % Comparison
For the Medical Devices subindustry, Bactiguard Holding AB's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bactiguard Holding AB Effective Interest Rate on Debt % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bactiguard Holding AB's Effective Interest Rate on Debt % distribution charts can be found below:
* The bar in red indicates where Bactiguard Holding AB's Effective Interest Rate on Debt % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data,
the Interest Expense data used here is four times the quarterly (Mar. 2026) interest expense data.
Effective Interest Rate on Debt % is displayed in the 30-year financial page.
What does a Effective Interest Rate on Debt % of 4.66% mean?
Bactiguard Holding AB (CHIX:BACTBS) has a Effective Interest Rate on Debt % of 4.66% as of Mar. 2026. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Bactiguard Holding AB and its competitors.
Is Bactiguard Holding AB's Effective Interest Rate on Debt % too high?
Bactiguard Holding AB's current Effective Interest Rate on Debt % is 4.66%. Overall, Bactiguard Holding AB has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.
How does Bactiguard Holding AB's Effective Interest Rate on Debt % compare to ABT and SYK?
Bactiguard Holding AB's Effective Interest Rate on Debt % of 4.66% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Effective Interest Rate on Debt % for a Medical Devices & Instruments company?
A good Effective Interest Rate on Debt % depends on the Medical Devices & Instruments industry context. However, Effective Interest Rate on Debt % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Effective Interest Rate on Debt % mean?
A high Effective Interest Rate on Debt % can signal that a stock is expensive relative to its fundamentals. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Bactiguard Holding AB and its competitors. Bactiguard Holding AB's current Effective Interest Rate on Debt % is 4.66%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bactiguard Holding AB stock overvalued right now?
Bactiguard Holding AB (CHIX:BACTBS) has a current Effective Interest Rate on Debt % of 4.66%. The stock's GF Value™ is kr269.74, compared to a current price of kr128.60 — trading 52.3% below its estimated fair value. The current Effective Interest Rate on Debt % is 4.66%. Bactiguard Holding AB's overall GF Score™ is 58/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Effective Interest Rate on Debt % calculated?
Effective Interest Rate on Debt % is calculated from a company's financial statements. For Bactiguard Holding AB (CHIX:BACTBS), the current Effective Interest Rate on Debt % is 4.66% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bactiguard Holding AB (CHIX:BACTBS) Overvalued in 2026?
Based on GuruFocus' analysis, Bactiguard Holding AB stock appears to be undervalued.
The current stock price of kr128.60 is trading 52.3% below its estimated GF Value™ of kr269.74.
Key valuation signals for CHIX:BACTBS:
Effective Interest Rate on Debt %: 4.66%
GF Value™: kr269.74 vs. price of kr128.60 (52.3% below fair value)
No single metric tells the full story. See the CHIX:BACTBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bactiguard Holding AB is a medical device company. It is engaged in a MedTech company developing safe and biocompatible technology to prevent medical device-related infections. The technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. The company focuses on five strategic therapeutic areas wherein infection rates create high medical needs for infection prevention. These areas include Orthopedics, Cardiology, Neurology, Urology, and Vascular Access. Geographically, the company operates in the USA, Malaysia, China, Saudi Arabia, Bangladesh, Sweden, the Czech Republic, and Other countries. The majority of its revenue is generated from the USA region.
58GF Score
Get the complete analysis for CHIX:BACTBS
Effective Interest Rate on Debt % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:BACTBS has been successfully added to your 
